Pfizer's CEO thinks his company will make big waves in the weight loss market. Eli Lilly does have a strong hold on the industry and won't let go anytime soon. Even so, Lilly could carve out a niche ...

Dr. Albert Bourla, chairman and CEO of drugmaker Pfizer, says mRNA technology is "extremely well-tested." - Dia Dipasupil/Getty Images Pharmaceutical rivals don’t often come to each other’s defense.

Pfizer CEO Albert Bourla is among those expected at a fundraiser President Trump is attending Friday at his golf club in Bedminster, New Jersey, sources told CBS News. The fundraiser for the pro-Trump ...

(CNN) — The GOP-led House Judiciary Committee is requesting records from Pfizer’s CEO and an interview with a former company executive to investigate an allegation that clinical testing related to the ...

Despite additional cost savings in 2026, Pfizer also forecasts that its adjusted earnings per share (EPS) will likely decline ...

By the beginning of 2025, it was clear the GLP-1 drugs were going to remain a major part of the industry. Pfizer used its presentation at the 43 rd JP Morgan Healthcre Conference to detail plans to ...

Pfizer (NYSE:PFE) CEO Albert Bourla is expected to meet with activist investor Starboard Value next week after the activist accumulated a $1 billion stake in the pharma giant. Bourla and at least one ...

Pfizer generated free cash flow of $10.4 billion in the 12 months ending Sept. 30, 2025. During this period, the pharma giant ...

Pfizer’s (PFE) ex-CEO Ian Read and ex-CFO Frank D’Amelio have retreated from activist investor Starboard Value’s campaign at the pharmaceutical giant. Guggenheim Securities, which acts as an advisor ...